- Category
- Micro (2022-23)
- Udyam number
- UDYAM-MH-27-0028745

Alphard Pharmaceuticals Private Limited
About Alphard Pharmaceuticals Private Limited
Data last updated:
Alphard Pharmaceuticals Private Limited is a private limited company based in Panvel, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 04 June 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2021PTC361622. Its GSTIN is 27AAVCA3008J1ZG (Maharashtra).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Raj Jain and Kavita Chadha.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at Sector 14, Panvel, Maharashtra.
As per the financials filed for FY 2022, the company reported a revenue of ₹28.23 Lakh. For the same year it recorded a net loss of ₹16.94 Lakh (net margin -60%) and EBITDA of -₹16.25 Lakh (EBITDA margin -57.6%).
As per MCA filings, the company has open charges of ₹10 Lakh on record.
Alphard Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-27-0028745).
Company details
Recognitions & Rankings of Alphard Pharmaceuticals
Contact details
Alphard Pharmaceuticals Private Limited's registered office is in Panvel, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressOffice No 1703 Kamdhenu Commerz, Sector 14 Kharghar, Panvel, Maharashtra, India – 410210
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Alphard Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Alphard Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Alphard Pharmaceuticals Private Limited, buy the company report.
Financials of Alphard Pharmaceuticals Private Limited
FY 2023 filings availableAlphard Pharmaceuticals Private Limited reported revenue of ₹28.23 Lakh for FY 2022.
Financial Statement Summary
| Metrics | FY 2021-22 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | ₹28.23 Lakh |
| Other Income | |
| Total Revenue | |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | -₹16.25 Lakh |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | -₹16.94 Lakh |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2021-22 |
|---|---|
| Profitability | |
| EBITDA Margin | -57.6% |
| Net Profit Margin | -60% |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Alphard Pharmaceuticals Private Limited, buy the company report.
Board of directors of Alphard Pharmaceuticals Private Limited
Alphard Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Raj Jain | Director | 04 Jun 2021 | 5 Years 4 Months | Current |
| Kavita Chadha | Director | 04 Jun 2021 | 5 Years 4 Months | Current |
Peer comparison
Alphard Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Kuiper Pharmaceuticals Private Limited | ₹28.33 Lakh (FY 2025) | 48.0% | Vikasnagar, Uttarakhand, India | |||
| Arobic Remedies and Pharmaceuticals Private Limited | ₹28.32 Lakh (FY 2022) | -29.0% | Nagpur, Maharashtra, India | |||
| Mormon Pharmaceuticals Private Limited | ₹28.26 Lakh (FY 2020) | -41.0% | Amravati, Maharashtra, India | |||
| Alphard Pharmaceuticals Private Limitedthis company | ₹28.23 Lakh (FY 2022) | -₹16.94 Lakh | -60% | Panvel, Maharashtra, India | ||
| Eshar Pharmaceuticals Private Limited | ₹28.21 Lakh (FY 2023) | 4.0% | Ahmedabad, Gujarat, India | |||
| Vvio Pharmaceuticals Private Limited | ₹28.04 Lakh (FY 2023) | Bangalore, Karnataka, India |
To see the full peer comparison of Alphard Pharmaceuticals Private Limited, buy the company report.
Auditor
Alphard Pharmaceuticals Private Limited is audited by JAIN PRATIK & CO. for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| JAIN PRATIK & CO. | FY 2022 | 157919 |
Shareholding
The shareholding of Alphard Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Alphard Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 15 Dec 2022 | 100685304 | Canara Bank | ₹10 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Alphard Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Alphard Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Alphard Pharmaceuticals Private Limited has 1 active EPFO establishment as of Apr 07, 2024.
GST
Alphard Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAVCA3008J1ZG | Maharashtra | Active | 23 Jun 2021 |
To see the full GST registrations and return filing status of Alphard Pharmaceuticals Private Limited, buy the company report.
Recent activity
Alphard Pharmaceuticals Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Kavita Chadha was appointed as Director on 04 Jun 2021.
Frequently asked questions
Alphard Pharmaceuticals is an active private limited company based in Panvel, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 04 June 2021 (5+ years old) and is registered under CIN U74999MH2021PTC361622.
Alphard Pharmaceuticals has 2 current directors:
- Raj Jain - Director
- Kavita Chadha - Director
The latest financial statements of Alphard Pharmaceuticals on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Alphard Pharmaceuticals is 27AAVCA3008J1ZG, registered in Maharashtra.
The CIN (Corporate Identification Number) of Alphard Pharmaceuticals is U74999MH2021PTC361622. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Alphard Pharmaceuticals was incorporated on 04 June 2021, making it 5+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Alphard Pharmaceuticals by revenue are Kuiper Pharmaceuticals Private Limited, Arobic Remedies and Pharmaceuticals Private Limited, Mormon Pharmaceuticals Private Limited, Eshar Pharmaceuticals Private Limited, Vvio Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Kavita Chadha was appointed as Director on 04 Jun 2021. Raj Jain was appointed as Director on 04 Jun 2021.
Yes, Alphard Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-27-0028745).
The registered office of Alphard Pharmaceuticals is at Office No 1703 Kamdhenu Commerz, Sector 14 Kharghar, Panvel, Maharashtra, India – 410210.
Alphard Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.

